B. Riley Wealth Advisors’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,588
Closed -$205K 1548
2024
Q1
$205K Buy
+3,588
New +$205K 0.01% 1265
2023
Q4
Sell
-3,588
Closed -$205K 1481
2023
Q3
$205K Sell
3,588
-160
-4% -$9.13K 0.01% 1265
2023
Q2
$230K Sell
3,748
-150
-4% -$9.19K 0.01% 1278
2023
Q1
$245K Sell
3,898
-115
-3% -$7.22K 0.01% 1182
2022
Q4
$255K Sell
4,013
-22
-0.5% -$1.4K 0.01% 1126
2022
Q3
$238K Buy
4,035
+47
+1% +$2.77K 0.01% 1140
2022
Q2
$231K Sell
3,988
-549
-12% -$31.8K 0.01% 980
2022
Q1
$282K Sell
4,537
-321
-7% -$20K 0.01% 1041
2021
Q4
$346K Sell
4,858
-55
-1% -$3.92K 0.01% 997
2021
Q3
$368K Hold
4,913
0.01% 932
2021
Q2
$380K Buy
4,913
+60
+1% +$4.64K 0.01% 904
2021
Q1
$359K Sell
4,853
-5
-0.1% -$370 0.01% 905
2020
Q4
$341K Buy
4,858
+20
+0.4% +$1.4K 0.02% 688
2020
Q3
$274K Sell
4,838
-131
-3% -$7.42K 0.01% 735
2020
Q2
$290K Buy
4,969
+38
+0.8% +$2.22K 0.02% 644
2020
Q1
$230K Sell
4,931
-811
-14% -$37.8K 0.02% 623
2019
Q4
$321K Sell
5,742
-15
-0.3% -$839 0.03% 571
2019
Q3
$273K Sell
5,757
-372
-6% -$17.6K 0.03% 623
2019
Q2
$328K Sell
6,129
-9,014
-60% -$482K 0.04% 526
2019
Q1
$836K Buy
15,143
+336
+2% +$18.6K 0.1% 218
2018
Q4
$697K Buy
14,807
+9,077
+158% +$427K 0.1% 221
2018
Q3
$341K Buy
5,730
+1,053
+23% +$62.7K 0.04% 453
2018
Q2
$256K Buy
4,677
+515
+12% +$28.2K 0.03% 528
2018
Q1
$205K Buy
+4,162
New +$205K 0.03% 581
2016
Q4
Sell
-15,726
Closed -$660K 607
2016
Q3
$660K Buy
15,726
+598
+4% +$25.1K 0.13% 196
2016
Q2
$560K Buy
15,128
+2,065
+16% +$76.4K 0.11% 221
2016
Q1
$500K Sell
13,063
-790
-6% -$30.2K 0.12% 225
2015
Q4
$700K Buy
13,853
+1,493
+12% +$75.4K 0.14% 181
2015
Q3
$566K Buy
12,360
+6,593
+114% +$302K 0.14% 210
2015
Q2
$337K Buy
+5,767
New +$337K 0.08% 305
2015
Q1
Sell
-1,620
Closed -$81 1550
2014
Q4
$81 Buy
+1,620
New +$81 ﹤0.01% 1834
2014
Q3
Sell
-1,241
Closed -$54.3K 1512
2014
Q2
$54.3K Buy
+1,241
New +$54.3K 0.01% 995